Study of the efficacy and safety of pilocarpine hydrochloride for vaginal dryness symptoms associated with atrophic vaginitis

Study of the efficacy and safety of pilocarpine hydrochloride for vaginal dryness symptoms associated with atrophic vaginitis - Study of the efficacy and safety of pilocarpine hydrochloride for vaginal dryness symptoms associated with atrophic vaginitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017282

Enrollment

Registered

2015-04-25

Start date

2011-06-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vaginal dryness symptoms associated with atrophic vaginitis

Interventions

oral administration of pilocarpine hydrochloride

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women aware of the vaginal drying symptoms associated with atrophic vaginitis symptoms

Exclusion criteria

Exclusion criteria: Patients with advanced renal function and liver dysfunction Patients who don not agree informed consent

Design outcomes

Primary

Measure	Time frame
vaginal drying symptoms	—

Countries

Japan

Contacts

Public ContactTakashi Iwata

Keio university school of medicine Obstetrics and Gynecology

iwatatakashi@1995.jukuin.keio.ac.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026